To date, only one published study by Li and colleagues (Li et al., 2014) revealed the involvement of CDKL2 in cancers, wherein they reported that expression of CDKL2 was remarkably higher in human breast cancer tissues and cells than that in their normal counterparts. The gene discussed is CDKL2; the disease is cancer.